Tag: drug infusion systems market outlook

  • Drug Infusion Systems Market Forecast 2026–2030: Market Size, Trends And Growth Opportunities

    Drug Infusion Systems Market Forecast 2026–2030: Market Size, Trends And Growth Opportunities

    Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

    Drug Infusion Systems Market Forecast: What Value Will The Market Reach By 2030?

    The drug infusion systems market has experienced significant expansion in recent years. It is forecast to grow from $14.23 billion in 2025 to $15.51 billion in 2026, at a compound annual growth rate (CAGR) of 9.0%. This past growth can be ascribed to elements such as an uptick in hospitalization rates, the increasing prevalence of chronic conditions, the expansion of oncology and chemotherapy interventions, the rising application of intravenous drug delivery, and improved access to infusion technologies.

    The drug infusion systems market size is projected to experience substantial growth in the upcoming years. It is set to expand to $22.23 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.4%. This anticipated growth during the forecast period stems from factors such as the increasing integration of connected infusion systems, a greater need for ambulatory and homecare infusion solutions, the broadening of precision drug delivery methods, an intensified emphasis on workflow automation within hospitals, and amplified investments in intelligent healthcare infrastructure. Key trends observed throughout the forecast period encompass a surge in the embrace of smart infusion pumps, increased incorporation of dose error reduction systems, wider utilization of multi-channel infusion devices, the proliferation of home-based infusion therapies, and a heightened emphasis on features designed for patient safety.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=51795851&type=smp&name=Drug%20Infusion%20Systems%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Drug Infusion Systems Market Growth Factors Behind Sustained Expansion

    Increasing healthcare expenditure is anticipated to boost the expansion of the drug infusion systems market in the future. Healthcare expenditure represents the overall sum allocated to healthcare products and services within a specific timeframe, usually a year. With a rise in healthcare spending, medical facilities such as hospitals and clinics acquire greater funds to invest in sophisticated drug infusion systems, consequently driving up the demand for these products. An example illustrating this trend is data from May 2024, where reports from the Office for National Statistics (ONS), a UK national statistical institute, indicated that total healthcare spending increased by 5.6% in nominal terms between 2022 and 2023, a significant jump from the 0.9% growth rate seen in 2022. Consequently, the expanding healthcare expenditure is projected to fuel the advancement of the drug infusion systems market.

    Drug Infusion Systems Market Segment Analysis Spotlighting Growth Areas

    The drug infusion systems market covered in this report is segmented –

    1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

    2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

    3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

    4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

    Subsegments:

    1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

    2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

    3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

    4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

    5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

    6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

    7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

    8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

    Drug Infusion Systems Market Industry Trends Fueling Future Revenue Growth

    Major companies in the drug infusion systems market are advancing technology, such as cloud-based infusion management systems, to enhance patient care, improve accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems are digital platforms that facilitate the monitoring, administration, and tracking of medication infusions via the cloud. For instance, in June 2023, Eitan Medical, a US-based global leader in advanced infusion therapy and drug delivery solutions, introduced Eitan Insights, a new cloud-based infusion management system specifically designed for the unique demands of home and specialty infusions. Eitan Insights is engineered to provide healthcare professionals with real-time data and analytics, enabling them to remotely oversee patients and modify treatment plans as necessary. This system improves medication safety by decreasing the likelihood of errors and enhancing adherence to prescribed protocols.

    Drug Infusion Systems Market Leading Players And Competitive Positioning

    Major companies operating in the drug infusion systems market are Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Smiths Group plc, Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc., Mindray Medical International Limited

    View The Full Drug Infusion Systems Market Report:

    https://thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Drug Infusion Systems Market Regional Distribution: Which Areas Power Market Growth?

    North America was the largest region in the drug infusion systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • The Drug Infusion Systems Market Is Witnessing Impact From Rising Healthcare Expenditure Drives Growth In The Drug Infusion Systems Market

    The Drug Infusion Systems Market Is Witnessing Impact From Rising Healthcare Expenditure Drives Growth In The Drug Infusion Systems Market

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Level Of Market Value Growth Is Predicted For The Drug Infusion Systems Market From 2026 To 2030?

    The drug infusion systems market size has experienced significant expansion recently. Projections indicate that this market will expand from $14.23 billion in 2025 to $15.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.0%. Historically, this expansion has been driven by factors such as escalating hospitalization rates, an increasing occurrence of chronic diseases, the broadening of oncology and chemotherapy treatments, a greater adoption of intravenous drug delivery methods, and enhanced access to infusion technologies.

    The drug infusion systems market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $22.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This projected growth during the forecast period can be linked to several factors, including the wider acceptance of connected infusion systems, an escalating need for ambulatory and homecare infusion options, the proliferation of precision drug delivery methods, a heightened emphasis on automating hospital workflows, and greater capital expenditure on intelligent healthcare infrastructure. Key developments expected in this period encompass the growing popularity of smart infusion pumps, the increasing incorporation of dose error reduction systems, the expanded deployment of multi-channel infusion devices, the wider availability of home-based infusion treatments, and a stronger emphasis on characteristics that ensure patient safety.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

    Which Strong Drivers Are Impacting The Drug Infusion Systems Market Growth?

    The drug infusion systems market is anticipated to experience growth driven by increasing healthcare expenditure. This refers to the total amount of money spent on healthcare goods and services within a specific timeframe, usually a year. As healthcare expenditures rise, hospitals, clinics, and other medical institutions acquire greater financial capacity to invest in advanced drug infusion systems, consequently stimulating demand for these devices. For example, in May 2024, reports from the Office for National Statistics (ONS), a national statistical institute located in the UK, indicated that total healthcare spending saw a nominal increase of 5.6% from 2022 to 2023, which is a considerable jump from the 0.9% growth rate observed in 2022. Therefore, the upward trend in healthcare expenditure is set to propel the expansion of the drug infusion systems market.

    How Are Segments Identified Within The Drug Infusion Systems Market Segment Framework?

    The drug infusion systems market covered in this report is segmented –

    1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

    2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

    3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

    4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

    Subsegments:

    1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

    2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

    3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

    4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

    5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

    6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

    7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

    8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

    Which Trends Are Contributing To Changes In The Drug Infusion Systems Market?

    Prominent companies in the drug infusion systems market are innovating with advanced technology, such as cloud-based infusion management systems, to elevate patient care, enhance accuracy, and optimize the handling of infusion therapies. Cloud-based infusion management systems serve as digital platforms that enable the monitoring, delivery, and tracking of medication infusions through cloud technology. As an illustration, in June 2023, Eitan Medical, a US-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a novel cloud-based infusion management system tailored for the specific demands of home and specialty infusions. Eitan Insights is designed to furnish healthcare professionals with real-time data and analytics, empowering them to oversee patients remotely and modify treatment plans as necessary. This system bolsters medication safety by lessening the chance of errors and improving compliance with prescribed protocols.

    Who Are The Companies Competing Within The Drug Infusion Systems Market?

    Major companies operating in the drug infusion systems market are Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Smiths Group plc, Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc., Mindray Medical International Limited

    Get The Full Drug Infusion Systems Market Report:

    https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

    Which Region Leads The Drug Infusion Systems Market In Overall Market Size?

    North America was the largest region in the drug infusion systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Drug Infusion Systems Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

    Browse Through More Reports Similar to the Global Drug Infusion Systems Market 2026, By The Business Research Company

    Infusion Pump Market Report 2026

    https://www.thebusinessresearchcompany.com/report/infusion-pump-global-market-report

    Intravenous Infusion Pumps Market Report 2026

    https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

    Perfusion Systems Market Report 2026

    https://www.thebusinessresearchcompany.com/report/perfusion-systems-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Drug Infusion Systems Market Developments and Growth Opportunities Across 2026–2030

    Drug Infusion Systems Market Developments and Growth Opportunities Across 2026–2030

    The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

    How Much Is The Drug Infusion Systems Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

    The drug infusion systems market size has experienced strong growth in recent years. It is projected to expand from $14.23 billion in 2025 to $15.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.0%. This historical increase can be attributed to factors such as increasing hospitalization rates, the rising prevalence of chronic diseases, the expansion of oncology and chemotherapy treatments, the growing use of intravenous drug delivery, and improved availability of infusion technologies.

    The market for drug infusion systems is projected to experience substantial expansion over the upcoming years. It is set to reach $22.23 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This anticipated growth during the prediction period can be ascribed to several factors, including the increasing use of connected infusion systems, a heightened demand for ambulatory and homecare infusion solutions, the broadening of precision drug delivery methods, an intensified emphasis on workflow automation within hospitals, and increased financial commitments to intelligent healthcare infrastructure. Key developments expected during this timeframe encompass the growing implementation of smart infusion pumps, a greater incorporation of dose error reduction systems, an expanding utilization of multi-channel infusion devices, the wider availability of home-based infusion therapies, and a stronger emphasis on characteristics that promote patient safety.

    Download the Free Sample Report to Explore Key Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

    Which Growth Drivers Are Contributing To The Progress Of The Drug Infusion Systems Market?

    Increasing spending on healthcare is anticipated to fuel expansion in the drug infusion systems market in the future. Healthcare expenditure represents the cumulative funds allocated to healthcare products and services within a specified timeframe, usually an annual period. A rise in healthcare spending equips hospitals, clinics, and other healthcare facilities with greater financial capacity to invest in sophisticated drug infusion systems, consequently boosting the demand for these products. For example, reports released by the UK’s Office for National Statistics (ONS) in May 2024 indicated that overall healthcare expenditure saw a nominal increase of 5.6% between 2022 and 2023, significantly higher than the 0.9% growth recorded in 2022. Consequently, the expansion of healthcare expenditure is projected to stimulate the growth of the drug infusion systems market.

    What Major Segment Divisions Exist Within The Drug Infusion Systems Market?

    The drug infusion systems market covered in this report is segmented –

    1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

    2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

    3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

    4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

    Subsegments:

    1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

    2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

    3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

    4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

    5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

    6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

    7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

    8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

    How Are Trends Shaping The Direction Of The Drug Infusion Systems Market?

    Major companies operating in the drug infusion systems market are developing advanced technologies, such as cloud-based infusion management systems, to improve patient care, enhance accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems serve as digital platforms that facilitate the monitoring, administration, and tracking of medication infusions through the cloud. For instance, in June 2023, Eitan Medical, a US-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a new cloud-based infusion management system tailored to meet the specific needs of home and specialty infusions. Eitan Insights is designed to provide healthcare professionals with real-time data and analytics, empowering them to monitor patients remotely and modify treatment plans as necessary. This system enhances medication safety by minimizing the risk of errors and improving adherence to prescribed protocols.

    Which Companies Are Leading Innovation In The Drug Infusion Systems Market?

    Major companies operating in the drug infusion systems market are Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Smiths Group plc, Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc., Mindray Medical International Limited

    Read the full drug infusion systems market report here:

    https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

    What Are The Leading Geographic Regions In The Drug Infusion Systems Market?

    North America was the largest region in the drug infusion systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Tailored Drug Infusion Systems Market Research Report For Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

    Browse Through More Reports Similar to the Global Drug Infusion Systems Market 2026, By The Business Research Company

    Infusion Pump Market Report 2026

    https://www.thebusinessresearchcompany.com/report/infusion-pump-global-market-report

    Intravenous Infusion Pumps Market Report 2026

    https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

    Perfusion Systems Market Report 2026

    https://www.thebusinessresearchcompany.com/report/perfusion-systems-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Drug Infusion Systems Market Research: Growth Projections and Trends 2030

    Drug Infusion Systems Market Research: Growth Projections and Trends 2030

    Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

    How much larger will the Drug Infusion Systems Market be in 2030 compared with 2026?

    The drug infusion systems market has experienced significant growth in recent years. This market is expected to expand from $14.23 billion in 2025 to $15.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.0%. The growth witnessed during the historic period can be ascribed to several factors, including increasing hospitalization rates, the rising prevalence of chronic diseases, the expansion of oncology and chemotherapy treatments, the growing utilization of intravenous drug delivery, and improved availability of infusion technologies.

    The market for drug infusion systems is projected to experience substantial growth over the coming years, anticipated to reach $22.23 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This expansion during the forecast period is driven by several factors, including the increasing use of connected infusion systems, a growing need for ambulatory and homecare infusion options, the proliferation of precision drug delivery methods, an intensified focus on automating hospital workflows, and increased funding for smart healthcare infrastructure. Key trends expected during this period involve the wider adoption of smart infusion pumps, greater integration of dose error reduction systems, the expanding utilization of multi-channel infusion devices, an increase in home-based infusion therapies, and a stronger emphasis on patient safety features.

    Access Your Free Sample Report for In-Depth Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

    What Drivers Are Guiding Growth Patterns In The Drug Infusion Systems Market?

    The increasing healthcare expenditure is anticipated to drive the future expansion of the drug infusion systems market. Healthcare expenditure refers to the total funds allocated to healthcare products and services within a specific period, typically a year. As spending on healthcare rises, hospitals, clinics, and other healthcare institutions gain more resources to invest in sophisticated drug infusion systems, thereby stimulating a greater demand for these devices. For example, reports published in May 2024 by the Office for National Statistics (ONS), a UK-based national statistical institute, revealed that total healthcare spending saw a nominal increase of 5.6% from 2022 to 2023, a considerable jump compared to the 0.9% growth rate recorded in 2022. Consequently, the rising healthcare expenditure is set to fuel the growth of the drug infusion systems market.

    How Is The Drug Infusion Systems Market Divided Into Segments?

    The drug infusion systems market covered in this report is segmented –

    1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

    2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

    3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

    4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

    Subsegments:

    1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

    2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

    3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

    4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

    5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

    6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

    7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

    8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

    Which Trends Are Influencing The Performance And Direction Of The Drug Infusion Systems Market?

    Leading firms within the drug infusion systems market are innovating with advanced technologies, including cloud-based infusion management systems, to elevate patient care, boost precision, and optimize the administration of infusion therapies. These cloud-based infusion management systems serve as digital platforms, enabling the oversight, delivery, and tracking of medication infusions through cloud technology. As an illustration, in June 2023, Eitan Medical, a US-based global leader in advanced infusion therapy and drug delivery solutions, unveiled Eitan Insights, which is a novel cloud-based infusion management system specifically tailored for the distinct requirements of home and specialty infusion settings. Eitan Insights aims to equip healthcare professionals with real-time data and analytical insights, allowing for remote patient monitoring and flexible adjustment of treatment plans. The system thereby improves medication safety, mitigating error risks and promoting better adherence to established protocols.

    Which Leading Companies Dominate The Drug Infusion Systems Market Share?

    Major companies operating in the drug infusion systems market are Medtronic plc, Baxter International Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Smiths Group plc, Terumo Corporation, Fresenius SE & Co. KGaA, ICU Medical Inc., Tandem Diabetes Care Inc., Insulet Corporation, Ypsomed Holding AG, Abbott Diabetes Care Inc., Flowonix Medical Inc., Zyno Medical Inc., IRadimed Corporation, Debiotech S.A., Valeritas Inc., Disetronic Medical Systems AG, Alaris Health Systems Inc., Hospira Inc., Mindray Medical International Limited

    Access The Complete Report For Deeper Market Insights:

    https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

    Which Region Is Anticipated To See The Fastest Growth In The Drug Infusion Systems Market?

    North America was the largest region in the drug infusion systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request Your Customized Drug Infusion Systems Market Research Report for Competitive Advantage:

    https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

    Browse Through More Reports Similar to the Global Drug Infusion Systems Market 2026, By The Business Research Company

    Infusion Pump Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/infusion-pump-global-market-report

    Intravenous Infusion Pumps Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report

    Perfusion Systems Global Market Report 2026

    https://www.thebusinessresearchcompany.com/report/perfusion-systems-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

  • Drug Infusion Systems Market Analysis 2025–2029: Growth Forecast and Competitive Insights

    Drug Infusion Systems Market Analysis 2025–2029: Growth Forecast and Competitive Insights

    Uncover key drivers, emerging technologies, and competitive movements shaping the drug infusion systems market from 2025–2034 with trusted insights from The Business Research Company

    How Much Will The Drug Infusion Systems Market Be Worth By 2029, And What CAGR Will It Achieve?

    The drug infusion systems market size has demonstrated robust expansion in recent years. This market is set to increase from $13.42 billion in 2024 to $14.23 billion in 2025, achieving a compound annual growth rate (CAGR) of 6.1%. This past growth can be ascribed to several factors, including the adoption of electronic infusion devices, a greater incidence of chronic diseases, developments in patient care, the rise of home-based infusion therapy, and the enlargement of ambulatory care settings.

    The market size for drug infusion systems is projected to experience substantial expansion over the coming years. It is anticipated to reach $20.23 billion by 2029, achieving a compound annual growth rate (CAGR) of 9.2%. This anticipated growth during the forecast period can be attributed to several factors, including a move towards disposable systems, the increasing prevalence of chronic illnesses, the expansion of ambulatory care facilities, advancements in personalized medicine and adaptive dosing, and a growing need for home-based care. Key trends expected during this period encompass wireless connectivity and remote monitoring, the integration with electronic health records (EHR), the advent of smart pump technology, continued focus on personalized and adaptive dosing, and the development of minimally invasive infusion techniques.

    Access A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

    Which Factors Are Driving The Drug Infusion Systems Market Forward?

    The expanding occurrence of chronic illnesses is projected to fuel the expansion of the drug infusion system market moving ahead. Conditions like cancer, diabetes, cardiovascular ailments, and autoimmune disorders frequently necessitate prolonged or uninterrupted infusion treatment. These systems provide a secure, effective, and efficient method for delivering medicines to individuals suffering from such health issues. The prevalence has been rising at a faster rate in low- and middle-income countries compared to high-income nations. Diabetes significantly contributes to kidney failure, heart attacks, strokes, vision loss, and lower limb amputations. For example, in February 2024, data from the Centers for Disease Control and Prevention (CDC), a US-based entity, indicated that an increasing proportion of the population in America is living with several chronic ailments, with 42% reporting two or more and 12% having five or more. Consequently, the escalating demand driven by the widespread incidence of chronic diseases propels the expansion of the drug infusion system market.

    Which Segments Form The Key Structure Of The Drug Infusion Systems Market?

    The drug infusion systemsmarket covered in this report is segmented –

    1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

    2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

    3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

    4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

    Subsegments:

    1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

    2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

    3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

    4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

    5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

    6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

    7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

    8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

    What Strategic Shifts And Innovations Are Influencing The Drug Infusion Systems Market?

    Major companies involved in the drug infusion systems market are developing advanced technology, such as cloud-based infusion management systems, to enhance patient care, improve accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems are digital platforms that facilitate the monitoring, administration, and tracking of medication infusions via the cloud. For instance, in June 2023, Eitan Medical, a US-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a new cloud-based infusion management system designed to meet the unique needs of home and specialty infusions. Eitan Insights is designed to provide healthcare professionals with real-time data and analytics, enabling them to monitor patients remotely and adjust treatment plans as needed. This system enhances medication safety by reducing the risk of errors and improving adherence to prescribed protocols.

    Which Firms Are Making The Biggest Impact In The Drug Infusion Systems Market?

    Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc.

    Download The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

    Which Region Is Expected To Lead The Drug Infusion Systems Market In The Next Few Years?

    North America was the largest region in the drug infusion systems market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Get A Report Customized For You Here:

    https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

    Browse Through More Reports Similar to the Global Drug Infusion Systems Market 2025, By The Business Research Company

    Cardiovascular Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

    Dermatology Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

    Gastrointestinal Drug Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Drug Infusion Systems Market Forecast: What to Expect by 2029

    Drug Infusion Systems Market Forecast: What to Expect by 2029

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    #What Is The Projected Market Size Of The Drug Infusion Systems Market By 2029?

    The overall volume of the drug infusion systems market has seen robust expansion lately, projected to advance from a valuation of $13.42 billion in 2024 to $14.23 billion the following year, reflecting a steady compound annual growth rate of 6.1%; this past period’s upward trajectory is largely owing to several key factors, including a notable transition toward electronic infusion apparatus, the rising incidence rates of long-term conditions, improvements made in patient treatment protocols, the increasing utilization of infusion therapies delivered in domestic settings, and the broader development of settings focused on outpatient care.

    Anticipated for the drug infusion systems industry is robust expansion over the forthcoming period, projecting the market’s valuation to reach $20.23 billion by 2029, propelled by a consistent compound annual growth rate (CAGR) of 9.2%. This upward trajectory anticipated through the forecast timeframe stems from several key factors, including the discernible pivot towards single-use systems, an increasing incidence of long-term medical conditions, the proliferation of outpatient treatment centers, advancements in customized medication delivery and dosage adjustment capabilities, and a heightened requirement for healthcare services delivered within domestic settings. Significant developments expected to shape the industry during this projection involve the adoption of wireless communication alongside remote patient oversight, the seamless incorporation of data exchange with electronic health records (EHR), the deployment of intelligent pump mechanisms, refined approaches to individualized and responsive administration of therapeutics, and the utilization of less invasive methods for administering infusions.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

    What Are The Main Drivers Boosting The Drug Infusion Systems Industry’s Expansion?

    The escalating incidence of long-term illnesses is anticipated to fuel the expansion of the market for drug infusion systems in the future. Therapies requiring sustained or ongoing administration of medication are often necessary for managing conditions like diabetes, cancer, autoimmune disorders, and cardiovascular ailments, and drug infusion devices provide a reliable, efficient, and successful method for delivering these necessary drugs. While the frequency of these diseases is rising across the globe, the acceleration in their prevalence is notably faster in countries categorized as low- and middle-income when contrasted with wealthier nations; specifically, diabetes stands out as a primary contributor to severe health outcomes, including strokes, blindness, heart attacks, amputation of lower limbs, and kidney failure. To illustrate the scope within the United States, data released by the Centers for Disease Control and Prevention (CDC) in February 2024 indicated a rising tide of individuals grappling with co-occurring chronic issues, showing that 42% of Americans manage at least two such long-term conditions, and a significant 12% cope with five or more complex health concerns, directly linking the expanding burden of these chronic conditions to the increased need for and subsequent growth in the drug infusion system market.

    What Are The Segment Types Shaping The Drug Infusion Systems Market?

    The drug infusion systemsmarket covered in this report is segmented –

    1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

    2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

    3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

    4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

    Subsegments:

    1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

    2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

    3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

    4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

    5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

    6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

    7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

    8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

    Which Ongoing Trends Are Expected To Shape The Drug Infusion Systems Market Outlook?

    Leading corporations operating within the drug infusion systems sector are actively creating cutting-edge technological solutions, notably cloud-based infusion management platforms, with the aim of elevating the standard of patient treatment, boosting precision, and optimizing the way infusion therapies are overseen. These cloud-based infusion management systems represent digital infrastructures permitting the observation, delivery, and precise record-keeping of medication infusions through remote, internet-based connections. For concrete illustration, in the month of June 2023, performance by Eitan Medical, a prominent worldwide developer of sophisticated infusion treatment and medication dispensing tools based in the United States, included the introduction of Eitan Insights, a newly developed system for infusion management hosted in the cloud, specifically tailored to address the distinct requirements of infusions administered at home or in specialized settings. Eitan Insights has been engineered to furnish medical practitioners with up-to-the-minute metrics and analytical findings, thereby empowering them to perform remote patient surveillance and make necessary modifications to treatment regimens without delay. As a resultant benefit, this platform significantly bolsters the security of medication administration by mitigating potential mistakes and fostering greater conformity with established treatment guidelines.

    Who Are The Prominent Global Companies Shaping The Drug Infusion Systems Market?

    Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc.

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

    Which Region Is Projected To Lead The Drug Infusion Systems Market During The Forecast Period?

    North America was the largest region in the drug infusion systems market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Request A Customized Version Of The Drug Infusion Systems Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

    Browse Through More Reports Similar to the Global Drug Infusion Systems Market 2025, By The Business Research Company

    Cardiovascular Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

    Dermatology Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

    Gastrointestinal Drug Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Drug Infusion Systems Market Size, Share & Trends Analysis Report By Product | Forecast to 2029

    Drug Infusion Systems Market Size, Share & Trends Analysis Report By Product | Forecast to 2029

    Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

    What Are The Future Growth Projections For The Drug Infusion Systems Market Size?

    The market size for drug infusion systems has seen significant expansion in the past few years. The projected growth for this market is from $13.42 billion in 2024 to $14.23 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. Factors that have contributed to growth during the historic period include the transition to electronic infusion devices, a higher incidence of chronic conditions, improvements in patient care, the rise of home-based infusion therapy, and the growth of ambulatory care environments.

    Expectations are high for substantial growth in the drug infusion systems industry in the forthcoming years, with the market predicted to rise to $20.23 billion by 2029 boasting a compound annual growth rate (CAGR) of 9.2%. The foreseeable expansion over this period is largely due to a transition toward disposable apparatus, escalating rates of persistent health conditions, the proliferation of outpatient care services, tailor-made medication and adaptable dosing, coupled with inflated demand for medical care at home. The forecast period will also see significant trends emerge such as remote tracking and wireless connectivity, integration with digital health records, innovative smart pump technology, personalized and flexible dosing, and less invasive infusion practices.

    Get A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

    Which Factors Are Steering Growth In The Drug Infusion Systems Market?

    The escalation in occurrences of chronic conditions is anticipated to spur the advancement of the drug infusion system market. Conditions such as cancer, diabetes, cardiovascular and autoimmune disorders often necessitate long-term or persistent infusion therapy. For patients with these ailments, drug infusion systems provide a safe, efficient, and efficacious method for medication administration. Compared to wealthier nations, the rate of occurrences has been escalating more swiftly in lesser to middle-income countries. Diabetes is a primary cause of renal failure, heart attacks, strokes, blindness, and lower limb amputation. For example, in February 2024, the Centers for Disease Control and Prevention (CDC), a US-based agency, reported that there is a rising number of Americans coping with numerous chronic conditions, with 42% having two or more and 12% having five or more. Hence, this surge in necessity due to the escalating prevalence of chronic illnesses propels the growth of the drug infusion system market.

    How Is The Drug Infusion Systems Market Organized By Different Segments?

    The drug infusion systemsmarket covered in this report is segmented –

    1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

    2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

    3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

    4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

    Subsegments:

    1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

    2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

    3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

    4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

    5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

    6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

    7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

    8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

    What Current And Upcoming Trends Are Shaping The Drug Infusion Systems Market?

    Prominent enterprises in the drug infusion systems market are investing in high-end technologies such as cloud-based infusion management systems to optimize patient care, enhance precision, and simplify administering infusion treatments. These cloud-based systems serve as virtual platforms enabling the overseeing, facilitation, and tracking of medicinal infusion via online cloud networks. For instance, Eitan Medical, a renowned US-based company noted for its cutting-edge infusion therapy and pharmaceutical delivery solutions, unveiled Eitan Insights in June 2023. This new cloud-based infusion management system caters to the specific demands of home and niche infusions. Eitan Insights offers immediate data and analytical insights to medical professionals, empowering them to remotely supervise patients and modify treatment regimens as required. By minimizing the possibility of mistakes and ensuring compliance with recommended procedures, this system boosts the safety of medication administration.

    Who Are The Most Influential Companies In The Drug Infusion Systems Market?

    Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc.

    Access The Complete Report Here:

    https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

    Which Region Dominates The Drug Infusion Systems Market Today?

    North America was the largest region in the drug infusion systems market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Customize Your Report Here:

    https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

    Browse Through More Reports Similar to the Global Drug Infusion Systems Market 2025, By The Business Research Company

    Cardiovascular Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report

    Dermatology Drugs Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

    Gastrointestinal Drug Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Key Factors Fueling the Growth of the Drug Infusion Systems Market in 2025: Surge In Chronic Diseases Propels Growth In Drug Infusion System Market

    Key Factors Fueling the Growth of the Drug Infusion Systems Market in 2025: Surge In Chronic Diseases Propels Growth In Drug Infusion System Market

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Are the Key Projections for the CAGR of the Drug Infusion Systems Market Size From 2025 to 2034?

    The market for drug infusion systems has seen robust growth in the recent past. It’s projected to escalate from $13.42 billion in 2024 to $14.23 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. Reasons behind the growth in the preceding period include the transition towards electronic infusion devices, heightened occurrence of chronic illnesses, improvements in patient care, the rise in home-infusion therapies, and the broadening of ambulatory care settings.

    In the coming years, the market size for drug infusion systems is anticipated to experience robust expansion. By 2029, it is projected to reach a worth of $20.23 billion, with a compound annual growth rate (CAGR) of 9.2%. This growth during the forecasted period can be credited to a shift toward disposable systems, an increasing prevalence of chronic illnesses, the widening of ambulatory care facilities, personalized medicine, and adaptive dosing, along with a growing demand for care at home. Key trends that are predicted to emerge in this period consist of wireless connectivity and remote monitoring, mergers with electronic health records (ehr), advancements in smart pump technology, personalized and adaptive dosing, and minimally invasive infusion methods.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

    What are the Fundamental Drivers and Innovations Shaping the Drug Infusion Systems Market?

    The escalating frequency of chronic illnesses is predicted to bolster the expansion of the drug infusion system market in the future. Long-term or perpetual infusion treatment is often required for chronic diseases like cancer, diabetes, cardiovascular disease, and autoimmune disorders. Drug infusion systems provide a secure, efficient, and potent method to dispense medication to people suffering from these conditions. The rates of these diseases have been rising at a faster pace in low-income and middle-income countries in comparison to affluent nations. Diabetes is a major contributory factor to renal failure, heart attacks, strokes, blindness, and amputation of lower limbs. For example, the Centers for Disease Control and Prevention (CDC), based in the US, reported in February 2024 that an increasing number of Americans are dealing with multiple chronic illnesses, with 42% having at least two and 12% having five or more. Thus, the augmenting demand stemming from the higher occurrence of chronic diseases propels the growth of the drug infusion system market.

    How Is the Drug Infusion Systems Market Segmented?

    The drug infusion systemsmarket covered in this report is segmented –

    1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

    2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

    3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

    4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

    Subsegments:

    1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

    2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

    3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

    4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

    5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

    6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

    7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

    8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

    Which Regions Are Driving the Next Phase of the Drug Infusion Systems Market Growth?

    North America was the largest region in the drug infusion systems market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Key Trends Are Shaping the Future of the Drug Infusion Systems Market?

    Renowned firms in the drug infusion systems market are focusing on innovations such as cloud-based infusion administration systems to boost patient care, enhance precision, and make the management of infusion treatments more efficient. Such systems represent digital infrastructures that leverage cloud technology to monitor, administer and keep track of medication infusions. For example, Eitan Medical, an international frontrunner from the U.S. in providing sophisticated infusion therapy and drug delivery solutions, debuted Eitan Insights, its new cloud-based infusion administration system, in June 2023. This system caters to the distinct requirements of home and specialty infusions. Eitan Insights is built to offer healthcare professionals access to real-time information and analytics, empowering them to supervise patients remotely and change treatment strategies if necessary. The system bolsters medication safety by minimizing errors and enhancing adherence to prescribed procedures.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

    How Is the Drug Infusion Systems Market Defined and What Are Its Core Parameters?

    Drug infusion systems are medical devices that are used to deliver medications and fluids into a patient’s body through a catheter or needle. Drug infusion systems are commonly used in hospitals, clinics, and other healthcare settings to administer medications, such as pain relief drugs, antibiotics, chemotherapy drugs, and fluids, to patients.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10703

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Key Factors Fueling the Growth of the Drug Infusion Systems Market in 2025: Surge In Chronic Diseases Propels Growth In Drug Infusion System Market

    Key Factors Fueling the Growth of the Drug Infusion Systems Market in 2025: Surge In Chronic Diseases Propels Growth In Drug Infusion System Market

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Are the Key Projections for the CAGR of the Drug Infusion Systems Market Size From 2025 to 2034?

    The market for drug infusion systems has seen robust growth in the recent past. It’s projected to escalate from $13.42 billion in 2024 to $14.23 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. Reasons behind the growth in the preceding period include the transition towards electronic infusion devices, heightened occurrence of chronic illnesses, improvements in patient care, the rise in home-infusion therapies, and the broadening of ambulatory care settings.

    In the coming years, the market size for drug infusion systems is anticipated to experience robust expansion. By 2029, it is projected to reach a worth of $20.23 billion, with a compound annual growth rate (CAGR) of 9.2%. This growth during the forecasted period can be credited to a shift toward disposable systems, an increasing prevalence of chronic illnesses, the widening of ambulatory care facilities, personalized medicine, and adaptive dosing, along with a growing demand for care at home. Key trends that are predicted to emerge in this period consist of wireless connectivity and remote monitoring, mergers with electronic health records (ehr), advancements in smart pump technology, personalized and adaptive dosing, and minimally invasive infusion methods.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

    What are the Fundamental Drivers and Innovations Shaping the Drug Infusion Systems Market?

    The escalating frequency of chronic illnesses is predicted to bolster the expansion of the drug infusion system market in the future. Long-term or perpetual infusion treatment is often required for chronic diseases like cancer, diabetes, cardiovascular disease, and autoimmune disorders. Drug infusion systems provide a secure, efficient, and potent method to dispense medication to people suffering from these conditions. The rates of these diseases have been rising at a faster pace in low-income and middle-income countries in comparison to affluent nations. Diabetes is a major contributory factor to renal failure, heart attacks, strokes, blindness, and amputation of lower limbs. For example, the Centers for Disease Control and Prevention (CDC), based in the US, reported in February 2024 that an increasing number of Americans are dealing with multiple chronic illnesses, with 42% having at least two and 12% having five or more. Thus, the augmenting demand stemming from the higher occurrence of chronic diseases propels the growth of the drug infusion system market.

    How Is the Drug Infusion Systems Market Segmented?

    The drug infusion systemsmarket covered in this report is segmented –

    1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

    2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

    3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

    4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

    Subsegments:

    1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

    2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

    3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

    4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

    5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

    6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

    7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

    8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

    Which Regions Are Driving the Next Phase of the Drug Infusion Systems Market Growth?

    North America was the largest region in the drug infusion systems market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Key Trends Are Shaping the Future of the Drug Infusion Systems Market?

    Renowned firms in the drug infusion systems market are focusing on innovations such as cloud-based infusion administration systems to boost patient care, enhance precision, and make the management of infusion treatments more efficient. Such systems represent digital infrastructures that leverage cloud technology to monitor, administer and keep track of medication infusions. For example, Eitan Medical, an international frontrunner from the U.S. in providing sophisticated infusion therapy and drug delivery solutions, debuted Eitan Insights, its new cloud-based infusion administration system, in June 2023. This system caters to the distinct requirements of home and specialty infusions. Eitan Insights is built to offer healthcare professionals access to real-time information and analytics, empowering them to supervise patients remotely and change treatment strategies if necessary. The system bolsters medication safety by minimizing errors and enhancing adherence to prescribed procedures.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

    How Is the Drug Infusion Systems Market Defined and What Are Its Core Parameters?

    Drug infusion systems are medical devices that are used to deliver medications and fluids into a patient’s body through a catheter or needle. Drug infusion systems are commonly used in hospitals, clinics, and other healthcare settings to administer medications, such as pain relief drugs, antibiotics, chemotherapy drugs, and fluids, to patients.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10703

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Europe +44 7882 955267

    Asia & Others +44 7882 955267 & +91 8897263534

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Drug Infusion Systems Industry Valued at $20.46 Billion by 2029 With CAGR of 9.3% | Size and Share Insights

    Drug Infusion Systems Industry Valued at $20.46 Billion by 2029 With CAGR of 9.3% | Size and Share Insights

    Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

    What Is the Forecast for the Drug Infusion Systems Market from 2024 to 2025?

    The market size for drug infusion systems has seen significant expansion in the past few years. The market, valued at $13.42 billion in 2024, is predicted to reach $14.34 billion in 2025, showing a compound annual growth rate (CAGR) of 6.9%. The historic growth of this market is linked to several key factors, including the transition to electronic infusion devices, a rise in chronic diseases, progress in patient care strategies, the adoption of home-based infusion treatments, and the growth of ambulatory care settings.

    What Is the Projected Market Size of the Drug Infusion Systems Market?

    The market for drug infusion systems is anticipated to experience robust growth in the upcoming years. The market is projected to surge to “$20.46 billion by 2029, boasting a compound annual growth rate (CAGR) of 9.3%. The anticipated growth during this period is mainly due to a shift towards disposable systems, an increasing incidence of chronic illnesses, the development of ambulatory care facilities, customised medication and adaptive dosing, along with a growing demand for in-home care. Key trends expected during this forecast period involve wireless connectivity, remote monitoring, integration into electronic health records (EHR), smart pump technology, personalised and adaptive dosing, and less invasive infusion methods.

    Download The Free Sample Report Here:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp

    Who are the Major Competitors in the Drug Infusion Systems Market Outlook?

    Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc.

    What Is Fueling Growth in the Drug Infusion Systems Market?

    The escalation in the occurrence of chronic diseases is anticipated to stimulate the expansion of the drug infusion system market. Conditions such as cancer, diabetes, cardiovascular disease, and autoimmune disorders often necessitate enduring or constant infusion therapy. Drug infusion systems provide a secure, efficient, and effective method to dispense medication to patients with these ailments. The prevalence has been escalating at a faster pace in low- and middle-income nations compared to wealthier countries. Diabetes is a primary cause of renal failure, heart attacks, strokes, blindness, and lower limb amputation. For instance, in February 2024, as per the findings published by Centers for Disease Control and Prevention (CDC), a US-based entity, they reported an increasing population in America is grappling with multiple chronic conditions, with 42% experiencing two or more and 12% enduring five or more. Hence, the growth of the drug infusion system market is driven by the surge in demand due to the increasing occurrence of chronic diseases.

    Request For A Customized Report:

    https://www.thebusinessresearchcompany.com/customise?id=10703&type=smp

    Which Drug Infusion Systems Market Segments Are Growing the Fastest?

    The drug infusion systems market covered in this report is segmented –

    1) By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System

    2) By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration

    3) By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications

    4) By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

    Subsegments:

    1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps, Vented Elastomeric Pumps

    2) By Disposable Infusion System: Disposable Infusion Pumps, IV Sets With Disposable Components

    3) By Syringe Infusion System: Manual Syringe Infusion Pumps, Electric Syringe Infusion Pumps

    4) By Peristaltic Pump: Single-Channel Peristaltic Pumps, Multi-Channel Peristaltic Pumps

    5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use, Multi-Channel Pumps For Specific Therapies

    6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps, Mechanical PCA Pumps

    7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Patch Insulin Pumps

    8) By Implantable Infusion System: Implantable Pumps For Chronic Pain, Implantable Pumps For Chemotherapy

    Which Industry Trends Are Shaping the Future of the Drug Infusion Systems Market?

    Prominent firms in the drug infusion systems market are innovating and introducing advanced technology like cloud-based infusion management systems to optimize patient care, increase accuracy, and simplify the management process of infusion treatments. These are digital platforms hosted on the cloud that aid in observance, administration, and tracing of medication infusions. To illustrate, Eitan Medical, a prominent leader in advanced infusion therapy and drug delivery based in the US, introduced Eitan Insights in June 2023 – a state-of-the-art cloud-based infusion management system fashioned to cater to the specific requirements of home and specialty infusions. This system is built to furnish healthcare workers with real-time data and analytics, empowering them to supervise patients remotely and make necessary adjustments to treatment plans. Eitan Insights effectively enhances drug safety by decreasing the likelihood of mistakes and upholding adherence to prescribed procedures.

    Access The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

    Which Countries Are Leading the Drug Infusion Systems Market?

    North America was the largest region in the drug infusion systems market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Purchase The Full Report Today:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10703

    This Report Delivers Insight On:

    1. How big is the drug infusion systems market, and how is it changing globally?

    2. Who are the major companies in the drug infusion systems market, and how are they performing?

    3. What are the key opportunities and risks in the drug infusion systems market right now?

    4. Which products or customer segments are growing the most in the drug infusion systems market?

    5. What factors are helping or slowing down the growth of the drug infusion systems market?

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model